Jeffrey M. Farma, MD, FACS
- Request Appointment
- Clinical Locations
- Education, Training & Credentials
- Patient Stories
- Research Profile
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Director, Surgical Oncology Fellowship
Co-Director, Cutaneous Oncology and Melanoma Program
Colorectal cancer, melanoma, sarcoma, minimally invasive and robotic surgery, isolated limb infusion for in-transit melanoma and extremity sarcomas.
It is an honor to be part of the staff of the Fox Chase Cancer Center. My initial exposure occurred during a rotation as a Temple University Medical School student at Fox Chase that led me down the path of Surgical Oncology. As a native Philadelphian, I am privileged to work at such an esteemed institution. I was enthralled then by the dedicated care of the staff in dealing with all aspects of treating patients diagnosed with cancer, and I hope to continue this throughout my career at Fox Chase.
I trained in general surgery at Temple University Hospital. During my fellowship at the National Cancer Institute in Bethesda, Maryland, I learned from experts in the field of surgical oncology about clinical trial design, experimental therapeutics and the importance of bench-to-bedside research to progress the fight against cancer. I encountered patients with very complex problems, and the greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.
My clinical surgical oncology fellowship at the Moffitt Cancer Center in Tampa, Florida has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer. One of the greatest benefits of a cancer center like Fox Chase is the close knit group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer. I have developed a particularly strong interest in the surgical and multimodal treatment of patients with Melanoma, Sarcoma and Colorectal cancers, using traditional surgery, regional therapies, and minimally invasive techniques. I have the operative expertise to perform many of these complex procedures using laparoscopic, robotic, and TAMIS (transaanal minimally invasive surgery) techniques and have had advanced training in using newest techniques. I am an expert in the treatment of colorectal cancer including; sphincter sparing and nerve sparing resections, and treating patients with hereditary colorectal cancer syndromes.
For melanoma and sarcoma that has regional spread in the extremities I offer a minimally invasive technique call Isolated Limb Infusion, and perform minimally invasive inguinal lymph node dissections.
Most importantly, I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions and providing guidance for each individual patient to help them throughout each stage of treatment. I believe in candid discussions, where both the patients and families goals and expectations are openly communicated. We will work together as a team to formulate a treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family m ember.
Follow on Twitter: @jeffreyfarma
- Surgical Oncology Fellow, Moffitt Cancer Center, Tampa, FL, 2009
- Administrative Chief Resident, Department of Surgery, Temple University Hospital, Philadelphia, PA, 2007
- Chief Resident, Temple University School of Medicine, Philadelphia, PA, 2006
- Surgical Oncology Fellow, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD, 2005
- Resident, Temple University School of Medicine, Philadelphia, PA, 2003
- MD, Temple University School of Medicine, Philadelphia, PA, 2000
- American Board of Surgery
- American College of Surgeons
- American College of Surgeons Oncology Group (ACOSOG)
- American Radium Society
- American Society of Colon and Rectal Surgeons
- Association of Academic Surgery- Candidate Member
- Connective Tissue Oncology Society (CTOS)
- Eastern Cooperative Oncology Group
- Metropolitan Philadelphia American College of Surgeons
- North American Neuroendocrine Tumor Society
- Philadelphia Academy of Surgery
- Society of Laparoendoscopic Surgeons
- Society of Surgical Oncology
- Society for Surgery of the Alimentary Tract
- Society of University Surgeon
- Surgical Biology Club III
Honors & Awards
- Castle Connelly national list of Top Doctors®, Regional Top Doctor 2014
- 2015 American College of Surgeons Traveling Fellowship to Germany, 2014
- Alpha Omega Alpha, National Medical Honor Society, Epsilon Chapter- Honorary Member, 2014
- H. Lee Moffitt Cancer Center 2008 Fellow’ Education Research Symposium, Best Clinical Poster Presentation, 2008
- Temple University Surgery Resident Research Symposium Award, 2007
- H. Taylor Caswell Award, Department of Surgery Teaching Award for outstanding Chief Surgical Resident, 2007
- ASCO Foundation Merit Award, 2005
In the spring of 2011, Michelle Palandro noticed a hard bump on her hip so she had her doctor check it out. The doctor ordered an X-ray which showed “fatty tissue in normal limits.” She followed her doctor’s recommendation and didn't worry about it, especially because she was so healthy and active. Then in July, after a moderate mountain hike, she developed excruciating pain in her lower leg. She went to a general surgeon to have the growth removed the following month. Tests revealed she had malignant stage 3 liposarcoma, a type of tumor that grows within the fat cells in deep soft tissue.
Robert W. Smith’s story has a happy ending, but began with fear and uncertainty. In 1998, almost out of the blue, he noticed a lump on the side of his torso. “I was 54, healthy and I just felt this lump,” he recalls. He went to a community hospital where doctors ordered testing. The pathology report confirmed that Bob had fibrous spindle cell sarcoma.
In the spring of 2011, Michelle Santangelo noticed a hard bump on her hip, so she had her doctor check it out. The doctor ordered an X-ray which showed “fatty tissue in normal limits.” She followed her doctor’s recommendation, and didn't worry about it, especially because she was so healthy and active. Then in July, after a moderate mountain hike, she developed excruciating pain in her lower leg. She went to a general surgeon to have the growth removed the following month.
At each of the 13 races she's run since 2010, Mary Marczely always races to cross the finish line. The contest that meant the most to her was the race against the cancer she was diagnosed with in August 2010.
Mary, a busy mother of two sons, who were age two and four at the time of her diagnosis, started experiencing an odd tingling sensation in her left calf and foot. The discomfort grew into pain and numbness.
One cancer diagnosis is bad enough. Two in the same month is really over the top. But that’s exactly what Kathleen Marchek faced in August 2009 at the age of 54. Kathleen, now a retired teacher, had a lumpectomy for stage one breast cancer the same week she had a colonoscopy and was diagnosed with stage three rectal cancer. “It was around the same time that Farrah Fawcett died from anal cancer. I was just beside myself. The doctor said I had to take care of this immediately.”
Melanoma: Molecular profiling, outcomes research, clinical trials, immunotherapy.
Colorectal: Molecular and imaging profiling for rectal cancer, outcomes research, clinical trials, quality of life.
Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbrook BJ, Bilimoria KY, Jake Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. November 2015.
Schatz TP, Nassif MO, Farma JM. Extensive portal venous gas: Unlikely etiology and outcome. Int J Surg Case Rep. December 2014.
Yeo H, Niland J, Milne D, ter Veer A, Bekail-Saab T, Farma JM, Lai L, Skibber JM, Small W Jr, Wilkinson N, Schrag D, Weiser MR, Incidence of minimally invasive colorectal cancer surgery at national comprehensive cancer network centers. Journal of the National Cancer Institute. December 2014.
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in Treatment of Angiosarcoma: A Single Institution Experience. The American Journal of Surgery. April 2014.
Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM,. Perlis C Turaka A,. Absolute Lymphocyte Count: a Potential Prognostic Factor for Merkel Cell Carcinoma. Journal of the American Academy of Dermatology. March 2014.
Yeo H, Niland J, Milne D, Veer AT, Bekaii-Saab T, Farma JM, Lai L, Skibber J, Small W, Wilkenson N, Schrag D, Weiser M. Incidence of Minimally Invasive Colorectal Cancer Surgery at National Comprehensive Cancer Network Centers. Journal of the National Cancer Institute. Accepted for publication. January 2014.
Keller D, Thomay AA, Gaughan J, Wu H, Farma JM. Outcomes in Patients with Mucosal Melanomas. Journal of Surgical Oncology. October 2013.
Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM. A better prognosis for merkel cell carcinoma of unknown primary origin. American Journal of Surgery. July 2013.
Arrangoiz R, Papavasiliou P, Siripuapu V, Li T, Watson JC, Hoffman JP, Farma JM, Partial stomach-partitioning gastrojejunostomy as an alternative for palliation in patients with malignant gastric or duodenal outlet obstruction. American Journal of Surgery. May 2013.
Nitzkorski, James, Willis, A, Farma JM, Zhu F, Nick D, Sigurdson, E. Association of race and socioeconomic status and outcomes with patients with rectal cancer. Ann Surg Oncol. January 2013.
Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Reports in Transplantation. November 2012.
Farma JM, Zager JS, Barnica-elvir V, Puleo CA, Marzban SS, Rollison DE, Messina JL, Sondak VK. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol. November 2012.
Papavasiliou P, Arrangoiz R, Farma JM. Utility of PET/CT in the staging and treatment of patients with Merkel Cell Carcinoma and Melanoma. Journal of Nuclear Medicine and Radiation Therapy. S5-001 October 2012.
Dr. Jeffery Farma on PubMed